Skip to main content
OpenTrials

Clinical trial condition

Hereditary Angioedema

Explore clinical trials studying Hereditary Angioedema. Study availability and eligibility vary by location and protocol.

78 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Hereditary Angioedema trial results

Completed

An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema

NCT04307381

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Ionis Investigative Site Scottsdale, Arizona, United States
  • Ionis Investigative Site Santa Monica, California, United States
  • Ionis Investigative Site Plymouth, Minnesota, United States
  • Ionis Investigative Site Cincinnati, Ohio, United States
View Trial Details
Completed

A Study of Navenibart (STAR-0215) in Participants With Hereditary Angioedema

NCT05695248

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Medical Research of Arizona a Division of Allergy, Asthma & Immunology Associates, LTD. Scottsdale, Arizona, United States
  • Allergy & Asthma Clinic of Northwest Arkansas Bentonville, Arkansas, United States
  • Acuro Research, Inc. Little Rock, Arkansas, United States
View all 20 locations
View Trial Details
Completed

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

NCT06467084

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Birmingham, Alabama, United States
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site San Diego, California, United States
  • KalVista Investigative Site Santa Monica, California, United States
View all 24 locations
View Trial Details
Completed

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

NCT04618211

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +23 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Paradise Valley, Arizona, United States
  • Study site San Diego, California, United States
  • Study site Santa Monica, California, United States
View all 36 locations
View Trial Details
Completed

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

NCT06343779

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +27 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Paradise Valley, Arizona, United States
  • Study Site Little Rock, Arkansas, United States
  • Study Site San Diego, California, United States
View all 76 locations
View Trial Details
Completed

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

NCT05047185

Conditions
Angioedema, Angioedemas, Hereditary, C1 Esterase Inhibitor Deficiency, +23 more
Locations
  • Study site Birmingham, Alabama, United States
  • Study site Paradise Valley, Arizona, United States
  • Study site St Louis, Missouri, United States
  • Study Site Vienna, Austria
View all 19 locations
View Trial Details
Completed

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

NCT05259917

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Birmingham, Alabama, United States
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site Little Rock, Arkansas, United States
  • KalVista Investigative Site San Diego, California, United States
View all 66 locations
View Trial Details
Completed

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

NCT04208412

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • KalVista Investigative Site Scottsdale, Arizona, United States
  • KalVista Investigative Site Centennial, Colorado, United States
  • KalVista Investigative Site Chevy Chase, Maryland, United States
  • KalVista Investigative Site Cincinnati, Ohio, United States
View all 25 locations
View Trial Details

Related conditions